Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal regrafts.

D K Imagawa, J M Cecka

    Clinical Transplants
    |January 1, 1988
    PubMed
    Summary
    This summary is machine-generated.

    Second kidney transplants (regrafts) show lower survival rates than first transplants, especially within the first month. Optimal timing and HLA matching improve outcomes for regrafted patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

    Clinical radiology·2017
    Same author

    Paul I. Terasaki, PhD, 1929-2016.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    HLA high-resolution typing for sensitized patients: a solution in search of a problem?

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Kidney paired donation in the presence of donor-specific antibodies.

    Kidney international·2013
    Same author

    Hemostatic Agents in Hepatobiliary and Pancreas Surgery: A Review of the Literature and Critical Evaluation of a Novel Carrier-Bound Fibrin Sealant (TachoSil).

    ISRN surgery·2012
    Same author

    Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles

    Area of Science:

    • Nephrology
    • Transplantation Immunology
    • Clinical Outcomes Research

    Background:

    • Approximately 15% of kidney transplants are regrafts.
    • Second transplants have lower survival rates compared to first transplants, with a higher incidence of early graft loss.

    Purpose of the Study:

    • To analyze the outcomes of kidney retransplantation.
    • To identify factors influencing the success of second kidney transplants.

    Main Methods:

    • Retrospective analysis of kidney retransplantation data.
    • Comparison of survival rates between first and second kidney transplants.
    • Evaluation of demographic, immunological, and clinical factors affecting regraft survival.

    Main Results:

    Related Experiment Videos

    • One-year graft survival for regrafts was 66.1% (cadaveric) and 82.7% (living donor), versus 75.9% and 89.4% for first transplants, respectively.
    • Early graft loss (within 1 month) was a major cause of failure for second transplants (14.1% vs 6.5%).
    • Younger (<10) and older (>60) patients had poorer outcomes; HLA matching and pre-transplant PRA levels were significant predictors of success. Black recipients and Black donor regrafts to non-Black recipients had lower survival rates.

    Conclusions:

    • Kidney retransplantation is feasible but associated with reduced graft survival compared to primary transplants.
    • Careful patient selection, HLA matching, and consideration of factors like donor/recipient race and prior sensitization are crucial for optimizing regraft outcomes.
    • An optimal interval of 1-6 months between first graft failure and retransplantation may improve success rates.